AAAAAA

   
Results: 1-7 |
Results: 7
ADJUVANT ADAPTIVE IMMUNOTHERAPY WITH TUMOR-INFILTRATING LYMPHOCYTES AND MODULATED DOSES OF INTERLEUKIN-2 IN 22 PATIENTS WITH MELANOMA, COLORECTAL AND RENAL-CANCER, AFTER RADICAL METASTASECTOMY, AND IN 12 ADVANCED PATIENTS
Authors: RIDOLFI R FLAMINI E RICCOBON A DEPAOLA F MALTONI R GARDINI A RIDOLFI L MEDRI L POLETTI G AMADORI D
Citation: R. Ridolfi et al., ADJUVANT ADAPTIVE IMMUNOTHERAPY WITH TUMOR-INFILTRATING LYMPHOCYTES AND MODULATED DOSES OF INTERLEUKIN-2 IN 22 PATIENTS WITH MELANOMA, COLORECTAL AND RENAL-CANCER, AFTER RADICAL METASTASECTOMY, AND IN 12 ADVANCED PATIENTS, Cancer immunology and immunotherapy, 46(4), 1998, pp. 185-193
ADOPTIVE IMMUNOTHERAPY (TIL-2) AFTER METASTASECTOMY IN 34 PATIENTS WITH MELANOMA, COLORECTAL AND RENAL-CARCINOMA(IL)
Authors: RIDOLFI R DEPAOLA F FLAMINI E RICCOBON A RIDOLFI L
Citation: R. Ridolfi et al., ADOPTIVE IMMUNOTHERAPY (TIL-2) AFTER METASTASECTOMY IN 34 PATIENTS WITH MELANOMA, COLORECTAL AND RENAL-CARCINOMA(IL), European journal of cancer, 33, 1997, pp. 64-64
SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA AND OTHER CYTOKINES DO NOT CORRELATE WITH WEIGHT-LOSS AND ANOREXIA IN CANCER-PATIENTS
Authors: MALTONI M FABBRI L NANNI O SCARPI E PEZZI L FLAMINI E RICCOBON A DERNI S PALLOTTI G AMADORI D
Citation: M. Maltoni et al., SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA AND OTHER CYTOKINES DO NOT CORRELATE WITH WEIGHT-LOSS AND ANOREXIA IN CANCER-PATIENTS, Supportive care in cancer, 5(2), 1997, pp. 130-135
TIL CULTURE AND EXPANSION FROM 42 HUMAN TUMORS - REINFUSION FOR IMMUNOADOPTIVE THERAPY IN 15 PATIENTS - PRELIMINARY DATA
Authors: RIDOLFI R MALTONI R RICCOBON A FLAMINI E FEDRIGA R AMADORI D
Citation: R. Ridolfi et al., TIL CULTURE AND EXPANSION FROM 42 HUMAN TUMORS - REINFUSION FOR IMMUNOADOPTIVE THERAPY IN 15 PATIENTS - PRELIMINARY DATA, European journal of cancer, 31A, 1995, pp. 60-60
LIVER METASTASES FROM GASTRIC-CARCINOMA - REPORT OF A PATIENT TREATEDWITH ADOPTIVE IMMUNOTHERAPY (TUMOR-INFILTRATING LYMPHOCYTES PLUS INTERLEUKIN-2 AND SUBSEQUENTLY LOCAL-REGIONAL LYMPHOKINE-ACTIVATED KILLER-CELLS PLUS INTERLEUKIN-2)
Authors: FABBRI L RIDOLFI R RICCOBON A MALTONI R FLAMINI E FEDRIGA R FLAMIGNI A MIGLIORI G ORTOLANI F CALZOLARI F AMADORI D
Citation: L. Fabbri et al., LIVER METASTASES FROM GASTRIC-CARCINOMA - REPORT OF A PATIENT TREATEDWITH ADOPTIVE IMMUNOTHERAPY (TUMOR-INFILTRATING LYMPHOCYTES PLUS INTERLEUKIN-2 AND SUBSEQUENTLY LOCAL-REGIONAL LYMPHOKINE-ACTIVATED KILLER-CELLS PLUS INTERLEUKIN-2), Tumori, 81(6), 1995, pp. 445-449
A PHASE-II STUDY OF ADVANCED COLORECTAL-CANCER PATIENTS TREATED WITH COMBINATION 5-FLUOROURACIL PLUS LEUCOVORIN AND SUBCUTANEOUS INTERLEUKIN-2 PLUS ALPHA-INTERFERON
Authors: RIDOLFI R RICCOBON A FEDRIGA R PEZZI L SANTONI A MALTONI R FLAMINI E MILANDRI C VELOTTI F AMADORI D
Citation: R. Ridolfi et al., A PHASE-II STUDY OF ADVANCED COLORECTAL-CANCER PATIENTS TREATED WITH COMBINATION 5-FLUOROURACIL PLUS LEUCOVORIN AND SUBCUTANEOUS INTERLEUKIN-2 PLUS ALPHA-INTERFERON, Journal of chemotherapy, 6(4), 1994, pp. 265-271
QUANTITATIVE IMMUNOHISTOCHEMICAL DETERMINATION OF CATHEPSIN-D AND ITSRELATION WITH OTHER VARIABLES
Authors: VENERONI S DAIDONE MG DIFRONZO G CAPPELLETTI V AMADORI D RICCOBON A PARADISO A CORREALE M SILVESTRINI R
Citation: S. Veneroni et al., QUANTITATIVE IMMUNOHISTOCHEMICAL DETERMINATION OF CATHEPSIN-D AND ITSRELATION WITH OTHER VARIABLES, Breast cancer research and treatment, 26(1), 1993, pp. 7-13
Risultati: 1-7 |